Predicting drug activity against cancer cells by random forest models based on minimal genomic information and chemical properties.
A key goal of precision medicine is predicting the best drug therapy for a specific patient from genomic information. In oncology, cancers that appear similar pathologically can vary greatly in how they respond to the same drug. Fortunately, data from high-throughput screening programs often reveal...
Main Authors: | Alex P Lind, Peter C Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0219774 |
Similar Items
-
Simultaneous regression and classification for drug sensitivity prediction using an advanced random forest method
by: Kerstin Lenhof, et al.
Published: (2022-08-01) -
Genome-enabled prediction through quantile random forest for complex traits
by: Cristiane Botelho Valadares, et al.
Published: (2023-02-01) -
Prediction of Antimalarial Drug-Decorated Nanoparticle Delivery Systems with Random Forest Models
by: Diana V. Urista, et al.
Published: (2020-07-01) -
A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy
by: Emma Bigelow, et al.
Published: (2022-11-01) -
Opening the Random Forest Black Box of the Metabolome by the Application of Surrogate Minimal Depth
by: Soeren Wenck, et al.
Published: (2021-12-01)